drug

ATRN-119

Phase 2updated 3mo ago

by $APRE Aprea Therapeutics, Inc.

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying ATRN-119

phase2Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCsnot yet recruitingn=35
phase2Study Of ATRN-119 In Patients With Advanced Solid Tumorsactive not recruitingn=132

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 5m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

ATRN-119

Phase 2updated 3mo ago

by $APRE Aprea Therapeutics, Inc.

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying ATRN-119

phase2Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCsnot yet recruitingn=35
phase2Study Of ATRN-119 In Patients With Advanced Solid Tumorsactive not recruitingn=132

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 5m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

ATRN-119

all catalysts(0)

Trials studying ATRN-119

News(0)

Report a data issue

comments(0)

ATRN-119

all catalysts(0)

Trials studying ATRN-119

News(0)

Report a data issue

comments(0)